Archived News

November 12th, 2014

Managing Partner David Stone Comments in a November 5, 2013 BioWorld Today Article, on Pharmaceutical Company Johnson & Johnson’s Agreement to Pay Over $2.2 Billion to Resolve Criminal and Civil Claim

November 12th, 2014
The Wall Street Journal Reports on November 5, 2013 on Johnson & Johnson’s $2.2 Billion Settlement of Criminal and Civil Claims of Fraud In Promoting Drugs, Including Risperdal

November 4th, 2014

Managing Partner David Stone Speaker at American Conference Institute’s False Claims & Qui Tam Enforcement Conference on January 27-28, 2014

October 20th, 2014
Virgin Islands and its Public Finance Authority File Suit Against Buchanan, Ingersoll & Rooney and Bank of America Over IRS Disallowance of $219 Million Dollar Bond Issue

October 20th, 2014
David Stone of Stone & Magnanini Serves on Panel for International Securities Litigation

October 20th, 2014
David Stone of Stone & Magnanini to Argue War Fraud Case against Halliburton in the United States Supreme Court

November 18th, 2013

Attorney General Eric Holder’s Prepared Remarks At Johnson & Johnson Press Conference

November 4th, 2013
Stone & Magnanini LLP Announces $1.3 Billion Department of Justice False Claims Act Settlement With Johnson & Johnson and Janssen Pharmaceuticals

December 20th, 2010

Winston & Strawn Law Firm Sued For Malpractice as Part of Ken Starr Ponzi Scheme; Lawsuit Filed by Stone & Magnanini LLP

November 5th, 2010
Team led by David Stone and Robert Magnanini of Stone & Magnanini and the U.S. Government Settle $313 Million Case Against Forest Pharmaceuticals, Inc.

March 5th, 2009
New False Claims and Complex Commercial Litigation Firm Formed by David S. Stone and Robert A. Magnanini – Stone & Magnanini LLP